Literature DB >> 222112

Sequence of motor nerve terminal involvement in acrylamide neuropathy.

F G Jennekens, H Veldman, P Schotman, W H Gispen.   

Abstract

Acrylamide neuropathy is characterized by distal multifocal axonal degeneration. In this condition long and large myelinated fibers are affected more than sort and thin fibers. The purpose of the present study was to investigate the sequence of nerve terminal involvement. The study was limited to axons that belonged to one type of neuron, of approximately equal diameter but differing in length. Axon terminals from alpha motor neurons were investigated in five muscles from rats. The results show that the initial motor nerve terminal degeneration is widespread and not restricted to terminals of the longest axons with the largest volumes. It is suggested that the variation in degree of involvement of the motor nerve terminals is determined both by differences between endplates and the regenerative capacity of neurons.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222112     DOI: 10.1007/bf00684805

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  Physiological studies of the dying-back phenomenon. Muscle stretch afferents in acrylamide neuropathy.

Authors:  A J Sumner; A K Asbury
Journal:  Brain       Date:  1975-03       Impact factor: 13.501

Review 2.  A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms.

Authors:  P S Spencer; H H Schaumburg
Journal:  Can J Neurol Sci       Date:  1974-08       Impact factor: 2.104

3.  Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication.

Authors:  H H Schaumburg; H M Wiśniewski; P S Spencer
Journal:  J Neuropathol Exp Neurol       Date:  1974-04       Impact factor: 3.685

4.  Motor end-plate fine structure in acrylamide dying-back neuropathy: a sequential morphometric study.

Authors:  M Tsujihata; A G Engel; E H Lambert
Journal:  Neurology       Date:  1974-09       Impact factor: 9.910

5.  Axoplasmic flow in axonal neuropathies. I. Axoplasmic flow in cats with toxic neuropathies.

Authors:  W G Bradley; M H Williams
Journal:  Brain       Date:  1973-06       Impact factor: 13.501

6.  Peripheral neuropathy in rats produced by acrylamide.

Authors:  P M Fullerton; J M Barnes
Journal:  Br J Ind Med       Date:  1966-07

Review 7.  The significance of the "dying back" process in experimental and human neurological disease.

Authors:  J B Cavanagh
Journal:  Int Rev Exp Pathol       Date:  1964

8.  The effect of acrylamide on the peripheral nervous system of the baboon.

Authors:  A Hopkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-12       Impact factor: 10.154

9.  Polyneuropathies and CNS protein metabolism. III. Changes in protein synthesis rate induced by acrylamide intoxication.

Authors:  P Schotman; L Gipon; F G Jennekens; W H Gispen
Journal:  J Neuropathol Exp Neurol       Date:  1978 Nov-Dec       Impact factor: 3.685

10.  In vitro staining of intramuscular nerve endings.

Authors:  R H Evans; J Haynes; C J Morris; A L Woolf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-12       Impact factor: 10.154

View more
  4 in total

1.  Effects of acrylamide and botulinum toxin on horseradish peroxidase labelling of trigeminal motor neurons in the rat.

Authors:  S Kemplay; J B Cavanagh
Journal:  J Anat       Date:  1983-10       Impact factor: 2.610

2.  Selective effect on peripheral nerves after subchronic administration of acrylamide.

Authors:  R J Anderson
Journal:  Bull Environ Contam Toxicol       Date:  1981-12       Impact factor: 2.151

3.  The effect of tetraphenylporphinesulfonate (TPPS) on muscle end-plates in mice. An ultrastructural and quantitative study.

Authors:  I A Felix; A A Sima
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

4.  Alterations in nerve and muscle compound action potentials after acute acrylamide administration.

Authors:  R J Anderson
Journal:  Environ Health Perspect       Date:  1982-04       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.